FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Allele: Dmel\mskUAS.cLa
Open Close
General Information
Symbol
Dmel\mskUAS.cLa
Species
D. melanogaster
Name
Saccharomyces cerevisiae UAS construct a of Lorenzen
FlyBase ID
FBal0122947
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Also Known As
UAS-msk, UAS:msk
Key Links
Nature of the Allele
Progenitor genotype
Carried in construct
Cytology
Description

Expression of a full length msk cDNA is governed by UASt regulatory sequences.

Allele components
Component
Use(s)
Encoded product / tool
Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 0 )
Disease
Evidence
References
Modifiers Based on Experimental Evidence ( 0 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

Scer\GAL4twi.PU-mediated expression of mskScer\UAS.cLa perturbs the ability of embryonic muscles to firmly adhere to the tendon cells.

Scer\GAL4Mef2.PR-mediated expression of mskScer\UAS.cLa results in detached muscles in embryos.

Expression of mskScer\UAS.cLa, under the control of Scer\GAL4en-e16E in the posterior compartment boundary of the wing disrupts the anteroposterior compartment boundary. Expression of mskScer\UAS.cLa, under the control of Scer\GAL4en-e16E results in the fraction of cells in S-phase increasing compared to wild-type (27% compared to 16% for the control), as does the fraction of cells in G2/M (37% versus 32%), at the expense of cells in G1. Prolonged and elevated expression of mskScer\UAS.cLa, under the control of Scer\GAL4en-e16E results in severe disruption to the adult wing, with nearly normal anterior compartments and severely reduced posteriors due to caspase-dependent cell death (authors term this the `Twiggy wing'). These wings display loss of posterior tissue, including distal regions of veins L4 and L5, and fused posterior and anterior crossveins.

Expression of mskScer\UAS.cLa, under the control of Scer\GAL4GMR.PF at 18oC causes a roughening of the eye (a disruption of the facet pattern) and a loss of some red pigment; this is accentuated at 25oC (over the effect of Scer\GAL4GMR.PF alone). Reduced numbers of both photoreceptors and pigment cells occurs before the 60 hour pupal stage. Elevating the temperature to 25oC kills almost all retinal cells before the adult stage, but the cells are not yet lost in the 60 hour pupa.

When mskScer\UAS.cLa is expressed under the control of Scer\GAL4en-e16E, homozygous msk5 clones induced in the posterior wing can grow to a typical size of more than 100 cells, whereas homozygous msk5 clones induced in the anterior wing are typically composed of 8 cells or less, indicating that msk is required for the growth of cells in the wing. Expression of mskScer\UAS.cLa under the control of Scer\GAL4en-e16E results in the cross veins moving closer together than normal, so that they can fuse as one vein with high levels of mskScer\UAS.cLa expression. A small number of wing blisters are also seen.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Phenotype Manifest In
Suppressed by
Enhancer of
Suppressor of
Statement
Reference
Other
Additional Comments
Genetic Interactions
Statement
Reference

mbcD11.2/+ largely suppresses the muscle detachment phenotype of Scer\GAL4twi.PU mskScer\UAS.cLa embryos.

The extra veins in the adult wing induced by rhohs.PSt are strongly suppressed by the addition of ectopic mskScer\UAS.cLa (under the control of Scer\GAL4en-e16E). Reduction of EGFR pathway function in rl10a heterozygotes strongly suppresses the mskScer\UAS.cLa Scer\GAL4en-e16E `Twiggy wing' (exhibiting a nearly normal anterior compartment and severely reduced posterior compartments) phenotype. Coexpression of argosScer\UAS.cHa and mskScer\UAS.cLa, under the control of Scer\GAL4en-e16E, enhances the vein loss phenotype of argos to 100% in L4 and 100% in L5.

Xenogenetic Interactions
Statement
Reference

Co-expression of BacA\p35Scer\UAS.cHa with mskScer\UAS.cLa, under the control of Scer\GAL4en-e16E, significantly enhances the adult vein loss observed in BacA\p35Scer\UAS.cHa mutants, resulting in severely distorted wings with enlarged posterior compartments compared with the control anterior compartments (the `J.Lo wing').

Complementation and Rescue Data
Partially rescues
Comments

Expression of mskScer\UAS.cLa under the control of Scer\GAL4ey.PH rescues eye development in mosaic animals with homozygous msk5 eyes (generated using the EGUF system), with the exception of minor disorganisation at the posterior margin.

Images (0)
Mutant
Wild-type
Stocks (1)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (3)
Reported As
Symbol Synonym
mskScer\UAS.cLa
mskUAS.cLa
Name Synonyms
Saccharomyces cerevisiae UAS construct a of Lorenzen
Secondary FlyBase IDs
    References (7)